Method_NN for_IN Estimation_NP of_IN Low_NP Outer_NP Membrane_NP Permeability_NP to_TO beta-Lactam_NN Antibiotics_NNS The_DT outer_JJ membrane_NN of_IN gram-negative_JJ bacteria_NNS plays_VBZ a_DT major_JJ role_NN in_IN beta-lactam_NN resistance_NN as_IN it_PP slows_VBZ down_RB antibiotic_JJ entry_NN into_IN the_DT periplasm_NN and_CC therefore_RB acts_VBZ in_IN synergy_NN with_IN beta-lactamases_NNS and_CC efflux_NN systems_NNS ._SENT Up_RB to_TO now_RB ,_, the_DT quantitative_JJ estimation_NN of_IN low_JJ outer_JJ membrane_NN permeability_NN by_IN the_DT method_NN of_IN Zimmermann_NP and_CC Rosselet_NP was_VBD difficult_JJ because_IN of_IN the_DT secreted_VBN and_CC cell_NN surface-associated_JJ beta-lactamases_NNS ._SENT The_DT method_NN presented_VBD here_RB uses_VBZ the_DT acylation_NN of_IN a_DT highly_RB sensitive_JJ periplasmic_JJ penicillin-binding_NN protein_NN (_( PBP_NP )_) (_( BlaR-CTD_NP )_) to_TO assess_VB the_DT rate_NN of_IN beta-lactam_NN penetration_NN into_IN the_DT periplasm_NN ._SENT The_DT method_NN is_VBZ dedicated_VBN to_TO measurement_NN of_IN low_JJ permeability_NN and_CC is_VBZ only_RB valid_JJ when_WRB the_DT diffusion_NN rate_NN through_IN the_DT outer_JJ membrane_NN is_VBZ rate_NN limiting_VBG ._SENT Cytoplasmic_JJ membrane_NN associated_VBN PBPs_NNS do_VBP not_RB interfere_VB since_IN they_PP are_VBP acylated_JJ after_IN the_DT very_RB sensitive_JJ BlaR-CTD_NN ._SENT This_DT method_NN was_VBD used_VBN to_TO measure_VB the_DT permeability_NN of_IN beta-lactamase-deficient_JJ strains_NNS of_IN Enterobacter_NP cloacae_NNS and_CC Enterobacter_NN aerogenes_NNS to_TO benzylpenicillin_NN ,_, ampicillin_NP ,_, carbenicillin_NP ,_, cefotaxime_NN ,_, aztreonam_NP ,_, and_CC cephacetrile_NN ._SENT Except_IN for_IN that_DT of_IN cephacetrile_NN ,_, the_DT permeability_NN coefficients_NNS were_VBD equal_JJ to_TO or_CC below_IN 10-7_CD cm/s_NNS ._SENT For_IN cephacetrile_NN ,_, carbenicillin_NN ,_, and_CC benzylpenicillin_NN ,_, the_DT outer_JJ membrane_NN of_IN E._NP cloacae_NNS was_VBD 20_CD to_TO 60_CD times_NNS less_RBR permeable_JJ than_IN that_DT of_IN Escherichia_NP coli_NNS ,_, whereas_IN for_IN cefotaxime_NN ,_, aztreonam_NP ,_, and_CC ampicillin_NN it_PP was_VBD ,_, respectively_RB ,_, 400_CD ,_, 1,000_CD ,_, and_CC 700_CD times_NNS less_RBR permeable_JJ ._SENT The_DT permeability_NN coefficient_NN for_IN aztreonam_NP is_VBZ the_DT lowest_JJS ever_RB measured_JJ (_( P_NN =_SYM 3.2_CD x_NN 10-9_CD cm/s_NNS )_) ._SENT Using_VBG these_DT values_NNS ,_, the_DT MICs_NP for_IN a_DT beta-lactamase-overproducing_NN strain_NN of_IN E._NP cloacae_NNS were_VBD successfully_RB predicted_VBN ,_, demonstrating_VBG the_DT validity_NN of_IN the_DT method_NN ._SENT beta-Lactams_NNS are_VBP the_DT most_RBS potent_JJ and_CC widely_RB used_VBN antibiotics_NNS ,_, and_CC many_JJ studies_NNS have_VBP been_VBN devoted_VBN to_TO understanding_NN how_WRB bacteria_NNS increase_VB their_PP$ resistance_NN to_TO these_DT compounds_NNS ._SENT Gram-negative_JJ resistance_NN results_NNS mainly_RB from_IN the_DT interplay_NN between_IN four_CD independent_JJ factors_NNS :_: (_( i_NP )_) the_DT sensitivity_NN of_IN the_DT target_NN enzymes_NNS ,_, the_DT penicillin-binding_NN proteins_VBZ ,_, (_( ii_NNS )_) the_DT properties_NNS and_CC concentration_NN of_IN the_DT periplasmic_JJ beta-lactamases_NNS ,_, (_( iii_NNS )_) the_DT permeability_NN of_IN the_DT outer_JJ membrane_NN and_CC (_( iv_NN )_) the_DT efficiency_NN of_IN the_DT active_JJ efflux_NN system_NN ._SENT On_IN this_DT basis_NN ,_, a_DT model_NN which_WDT allowed_VBD a_DT quantitative_JJ prediction_NN of_IN the_DT MICs_NN for_IN gram-negative_JJ bacteria_NNS was_VBD developed_VBN and_CC applied_VBN with_IN success_NN to_TO Escherichia_NP coli_NNS and_CC Enterobacter_NN cloacae_NNS ._SENT However_RB ,_, as_IN demonstrated_VBN by_IN Livermore_NP and_CC Davy_NP ,_, this_DT model_NN was_VBD not_RB applicable_JJ to_TO Pseudomonas_NP aeruginosa_NP ,_, one_CD of_IN the_DT most_RBS common_JJ opportunistic_JJ pathogens_NNS ._SENT This_DT was_VBD due_JJ to_TO efflux_NN pumps_NNS which_WDT also_RB significantly_RB contribute_VB to_TO intrinsic_JJ beta-lactam_NN resistance_NN in_IN P._NP aeruginosa_NP ._SENT This_DT was_VBD unexpected_JJ ,_, because_IN beta-lactam_NN targets_NNS are_VBP located_VBN outside_IN the_DT cytoplasmic_JJ membrane_NN and_CC also_RB because_IN in_IN E._NP coli_NNS this_DT mechanism_NN does_VBZ not_RB produce_VB such_PDT a_DT high_JJ and_CC broad_JJ level_NN of_IN resistance_NN ._SENT Li_NP et_FW al._FW ,_, pointed_VBD out_RP that_IN the_DT low_JJ outer_JJ membrane_NN permeability_NN of_IN P._NP aeruginosa_NP renders_VBZ this_DT efflux_NN mechanism_NN particularly_RB efficient_JJ (_( 15_CD ,_, 16_CD )_) ._SENT In_IN fact_NN ,_, while_IN the_DT few_JJ permeability_NN coefficients_NNS (_( P_NN )_) published_VBN for_IN P._NP aeruginosa_NP are_VBP low_JJ ,_, they_PP are_VBP also_RB highly_RB variable_JJ ._SENT For_IN cephaloridine_NN and_CC nitrocefin_NN ,_, Nikaido_NP 's_POS group_NN reported_VBD P_NN values_NNS of_IN 10-6_CD and_CC 6_CD x_SYM 10-7_CD cm/s_NNS ,_, respectively_RB ,_, but_CC others_NNS have_VBP measured_VBN values_NNS equal_JJ to_TO or_CC less_JJR than_IN 2_CD x_NN 10-8_CD cm/s_NNS ._SENT All_PDT these_DT values_NNS were_VBD determined_VBN on_IN the_DT basis_NN of_IN the_DT method_NN of_IN Zimmermann_NP and_CC Rosselet_NP ,_, in_IN which_WDT the_DT hydrolysis_NN of_IN beta-lactam_NN by_IN intact_JJ cells_NNS is_VBZ compared_VBN to_TO that_DT obtained_VBN with_IN a_DT lysate_NN ._SENT The_DT analysis_NN is_VBZ then_RB based_VBN on_IN the_DT assumption_NN that_IN a_DT steady_JJ state_NN is_VBZ rapidly_RB established_VBN in_IN the_DT periplasm_NN ,_, where_WRB the_DT rate_NN of_IN penetration_NN of_IN the_DT antibiotic_NN which_WDT obeys_VBZ Fick_NP 's_POS law_NN of_IN diffusion_NN is_VBZ equal_JJ to_TO that_DT of_IN the_DT beta-lactamase-catalyzed_JJ hydrolysis_NN ,_, which_WDT follows_VBZ Henri-Michaelis_NP kinetics_NNS ._SENT If_IN the_DT validity_NN of_IN this_DT assumption_NN has_VBZ been_VBN demonstrated_VBN experimentally_RB ,_, the_DT method_NN is_VBZ not_RB accurate_JJ when_WRB beta-lactamase_NN activity_NN is_VBZ present_JJ in_IN the_DT medium_NN or_CC on_IN the_DT cell_NN surface_NN ._SENT Under_IN these_DT conditions_NNS ,_, the_DT error_NN introduced_VBD remains_VBZ negligible_JJ if_IN the_DT outer_JJ membrane_NN permeability_NN is_VBZ high_JJ ,_, as_RB with_IN E._NP coli_NNS ,_, but_CC when_WRB the_DT permeability_NN is_VBZ low_JJ ,_, as_RB with_IN P._NP aeruginosa_NP ,_, the_DT correction_NN factors_NNS range_VBP from_IN 4_CD to_TO 10_CD depending_VBG on_IN the_DT experimental_JJ conditions_NNS ,_, and_CC in_IN addition_NN it_PP should_MD be_VB carefully_RB verified_VBN that_IN steady-state_NN conditions_NNS really_RB prevail_VBP ._SENT It_PP is_VBZ therefore_RB not_RB surprising_JJ that_IN only_RB a_DT few_JJ P_NN values_NNS have_VBP been_VBN determined_VBN for_IN Enterobacter_NP and_CC Pseudomonas_NP species_NNS ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP have_VBP developed_VBN a_DT new_JJ method_NN based_VBN on_IN the_DT properties_NNS of_IN a_DT soluble_JJ ,_, periplasmic_JJ high-affinity_NN penicillin-binding_NN protein_NN (_( PBP_NP )_) which_WDT can_MD easily_RB be_VB used_VBN to_TO measure_VB low_JJ outer_JJ membrane_NN permeability_NN coefficients_NNS ._SENT This_DT PBP_NP is_VBZ the_DT C-terminal_JJ domain_NN of_IN the_DT BlaR_NP penicillin_NN sensory_JJ transducer_NN involved_VBN in_IN beta-lactamase_NN induction_NN in_IN Bacillus_NN licheniformis_NNS (_( M._NP Swinnen_NP ,_, S._NP Lepage_NP ,_, A._NP Brans_NP ,_, B._NP Granier_NP ,_, J._NP M._NP Frere_NP ,_, and_CC B._NP Joris_NP ,_, submitted_VBN for_IN publication_NN )_) ._SENT Bacterial_JJ strains_NNS and_CC plasmids_NNS ._SENT |_SYM Enterobacter_NP aerogenes_NNS 006_CD is_VBZ a_DT wild-type_NN strain_NN that_WDT produces_VBZ an_DT inducible_JJ beta-lactamase_NN ._SENT E._NP aerogenes_VBZ 008-4_CD is_VBZ a_DT beta-lactamase-deficient_JJ strain_NN obtained_VBN by_IN subjecting_VBG the_DT beta-lactamase-overproducing_NN strain_NN E._NP aerogenes_NNS 008_CD to_TO chemical_NN mutagenesis_NN ._SENT These_DT strains_NNS were_VBD kindly_RB provided_VBN by_IN N._NP A._NP C._NP Curtis_NP ._SENT The_DT resistant_JJ E._NP cloacae_NNS 908R_NN overproduces_VBZ a_DT class_NN C_NP beta-lactamase_NN ._SENT It_PP was_VBD obtained_VBN by_IN sequential_JJ passages_NNS on_IN increasing_VBG concentrations_NNS of_IN ceftriaxone_NN and_CC was_VBD kindly_RB given_VBN by_IN R._NP L._NP Then_NP (_( Hoffmann-LaRoche_NP ,_, Basel_NP ,_, Switzerland_NP )_) ._SENT E._NP cloacae_NNS AD2_NP is_VBZ a_DT beta-lactamase-negative_JJ mutant_JJ isogenic_NN to_TO E._NP cloacae_NNS 908R_NN ,_, obtained_VBN by_IN insertion_NN of_IN the_DT kanamycin_NN resistance_NN gene_NN in_IN the_DT chromosomal_JJ ampR-ampC_NN locus_NN ._SENT For_IN details_NNS about_IN the_DT construction_NN of_IN this_DT strain_NN see_VB reference_NN and_CC references_NNS given_VBN therein_RB ._SENT P._NP aeruginosa_NP PAO1_NP was_VBD kindly_RB provided_VBN by_IN D._NP M._NP Livermore_NP ._SENT Plasmids_NNS pDML309_NN and_CC pDML310_NN were_VBD constructed_VBN by_IN inserting_VBG the_DT 1.2-kb_JJ HindIII-BalI_NP fragment_NN of_IN plasmid_NP pRTW8_NN coding_VBG for_IN the_DT 256_CD residues_NNS of_IN the_DT C-terminal_JJ domain_NN of_IN the_DT BlaR_NP penicillin_NN sensory_JJ transducer_NN of_IN B._NP licheniformis_NP (_( BlaR-CTD_NP )_) in_IN plasmid_NP pIN-III-ompA_NP ._SENT This_DT vector_NN allows_VBZ periplasmic_JJ expression_NN of_IN proteins_NNS ._SENT It_PP contains_VBZ the_DT strong_JJ lppp_NP promoter_NN of_IN the_DT E._NP coli_NNS lipoprotein_NN controlled_VBN by_IN the_DT lac-UV5_JJ promoter-operator_NN ._SENT The_DT E._NP coliompA_NN signal_NN peptide_NN is_VBZ under_IN the_DT control_NN of_IN the_DT two_CD latter_JJ promoters_NNS and_CC a_DT polylinker_NN is_VBZ present_JJ just_RB at_IN the_DT end_NN of_IN the_DT ompA_NN signal_NN peptide_NN sequence_NN ._SENT The_DT ampicillin_NN resistance_NN gene_NN of_IN pIN-III-ompA_NN was_VBD replaced_VBN by_IN the_DT tetracycline_NN and_CC kanamycin_NN resistance_NN genes_NNS ,_, yielding_VBG pDML309_NN and_CC pDML310_NN ,_, respectively_RB (_( Swinnen_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT The_DT resulting_VBG plasmids_NNS were_VBD used_VBN to_TO transform_VB E._NP cloacae_NNS AD2_NP and_CC E._NP aerogenes_NNS 008-4_CD ,_, respectively_RB ._SENT Plasmid_NP pBL2_NN was_VBD used_VBN to_TO produce_VB BlaR-CTD_NN in_IN the_DT periplasm_NN of_IN P._NP aeruginosa_NP ._SENT It_PP was_VBD constructed_VBN by_IN ligating_VBG the_DT 5.8-kb_JJ PstI-HpaI_NP fragment_NN of_IN plasmid_NP pDML309_NN to_TO the_DT 5.9-kb_JJ PstI-PvuII_NP fragment_NN of_IN pKT240_NN (_( purchased_VBN from_IN the_DT Laboratorium_NP voor_NN Moleculaire_NP Biologie_NP Plasmidencollectie_NP culture_NN collection_NN ,_, University_NP of_IN Ghent_NP ,_, Ghent_NP ,_, Belgium_NP )_) ._SENT Antibiotics_NNS ._SENT |_SYM The_DT following_VBG compounds_NNS were_VBD kind_NN gifts_NNS of_IN various_JJ companies_NNS :_: carbenicillin_NN from_IN Beecham_NP (_( Brentford_NP ,_, United_NP Kingdom_NP )_) ,_, cefotaxime_NN from_IN Hoechst-Roussel_NP (_( Romainville_NP ,_, France_NP )_) ,_, cephaloridine_NN from_IN Eli-Lilly_NP (_( Indianapolis_NP ,_, Ind._NP )_) ,_, aztreonam_NP from_IN Squibb_NP (_( Princeton_NP ,_, N.J._NP )_) ,_, benzylpenicillin_NN from_IN Rhone-Poulenc_NP (_( Paris_NP ,_, France_NP )_) ,_, ampicillin_NN from_IN Bristol-Myers_NP Squibb_NP (_( Brussels_NP ,_, Belgium_NP )_) ,_, nitrocefin_NN from_IN Oxoid_NP (_( Basingstoke_NP ,_, United_NP Kingdom_NP )_) ,_, and_CC [_SYM 14C]cephacetrile_JJ (_( 4.5_CD mCi/mmol_NN )_) from_IN Ciba-Geigy_NP (_( Basel_NP ,_, Switzerland_NP )_) ._SENT 3H-_JJ and_CC 14C-labeled_JJ benzylpenicillin_NN (_( 19_CD Ci_NP and_CC 59_CD mCi/mmol_NN ,_, respectively_RB )_) were_VBD purchased_VBN from_IN Amersham_NP (_( Little_NP Chalfont_NP ,_, United_NP Kingdom_NP )_) ,_, and_CC tetracycline_NN and_CC kanamycin_NN were_VBD purchased_VBN from_IN Sigma_NP (_( St._NP Louis_NP ,_, Mo._NP )_) and_CC Merck_NP (_( Darmstadt_NP ,_, Germany_NP )_) ,_, respectively_RB ._SENT MIC_JJ determination_NN ._SENT |_SYM MICs_NP were_VBD determined_VBN in_IN Isosensitest_JJ broth_NN (_( Oxoid_JJ )_) with_IN serial_JJ doubling_NN dilutions_NNS of_IN the_DT antibiotics_NNS ._SENT For_IN each_DT antibiotic_JJ concentration_NN ,_, an_DT inoculum_NN of_IN 2_CD x_SYM 104_CD CFU_NP taken_VBN from_IN a_DT growing_VBG culture_NN in_IN Isosensitest_JJ broth_NN (_( A600_NP =_SYM 1_CD )_) ,_, was_VBD added_VBN to_TO 2_CD ml_NN of_IN medium_NN ._SENT Results_NNS were_VBD recorded_VBN after_IN a_DT 24-h_JJ incubation_NN at_IN 37C_JJ with_IN shaking_VBG (_( 200_CD rpm_NN )_) ._SENT The_DT MIC_NN was_VBD taken_VBN as_IN the_DT minimal_JJ antibiotic_JJ concentration_NN inhibiting_VBG bacterial_JJ growth_NN ._SENT Measurement_NN of_IN benzylpenicillin_NN hydrolysis_NN ._SENT |_SYM An_DT aliquot_NN of_IN cells_NNS was_VBD centrifuged_VBN at_IN 5,000_CD x_NN g_NN and_CC 4C_JJ for_IN 3_CD min_NN ._SENT A_DT 10-mul_NP aliquot_NN of_IN the_DT supernatant_JJ was_VBD applied_VBN to_TO a_DT silica_NN thin-layer_NN chromatography_NN plate_NN (_( Merck_NP )_) ,_, and_CC benzylpenicillin_NN was_VBD separated_VBN from_IN benzylpenicilloic_JJ acid_NN using_VBG chloroform-methanol-acetic_JJ acid_NN (_( 88:10:2_CD ,_, vol/vol/vol_NN )_) as_IN a_DT solvent_NN ._SENT SDS-PAGE_NN and_CC fluorography_NN ._SENT |_SYM Sodium_NP dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) and_CC fluorography_NN were_VBD performed_VBN according_VBG to_TO standard_JJ methods_NNS ._SENT Cell_NN fractionation_NN and_CC labeling_VBG with_IN fluorescent_JJ antibiotic_NN ._SENT |_SYM Enterobacter_NP cells_NNS were_VBD harvested_VBN by_IN centrifugation_NN when_WRB the_DT culture_NN had_VBD reached_VBN an_DT A600_NP value_NN of_IN 0.8_CD ;_: resuspended_VBN in_IN 30_CD mM_NP Tris-HCl_NP ,_, pH_NN 8_CD ,_, containing_VBG 27_CD %_NN sucrose_NN ,_, 5_CD mM_NP EDTA_NP ,_, and_CC lysozyme_NN (_( 0.5_CD mg/ml_NN )_) ;_: and_CC incubated_VBN at_IN 4C_JJ for_IN 20_CD min_NN ._SENT The_DT periplasmic_JJ fraction_NN was_VBD separated_VBN from_IN the_DT spheroplasts_NNS by_IN centrifugation_NN at_IN 30,000_CD x_NN g_NN for_IN 15_CD min_NN ._SENT To_TO lyse_VB the_DT spheroplasts_NNS ,_, they_PP were_VBD resuspended_VBN in_IN 10_CD mM_NP Tris-HCl_NP ,_, pH_NN 8_CD ,_, containing_VBG 10_CD mM_NP MgCl2_NP and_CC DNase_NP (_( 20_CD mug/ml_NN )_) ._SENT The_DT lysed_VBN spheroplasts_NNS are_VBP referred_VBN to_TO hereafter_NN as_IN the_DT cellular_JJ fraction_NN ._SENT For_IN P._NP aeruginosa_NP ,_, the_DT periplasmic_JJ fraction_NN was_VBD isolated_VBN by_IN three_CD freeze-thaw_NN cycles_NNS ._SENT Labeling_VBG of_IN the_DT periplasmic_JJ and_CC cellular_JJ fractions_NNS was_VBD performed_VBN with_IN 5'-fluoresceyl-glycyl-6-aminopenicillanic_JJ acid_NN (_( 5'-Flu-Gly-6APA_NP )_) as_IN previously_RB described_VBN ._SENT Determination_NN of_IN beta-lactamase_NN content_NN of_IN cells_NNS ._SENT |_SYM Aliquots_NP of_IN cells_NNS growing_VBG in_IN Isosensitest_JJ broth_NN were_VBD withdrawn_VBN after_IN various_JJ time_NN intervals_NNS ._SENT A_DT portion_NN (_( 50_CD %_NN )_) of_IN each_DT aliquot_NN was_VBD filtered_VBN on_IN a_DT Millipore_NP GVWP_NP filter_NN (_( pore_NN size_NN ,_, 0.2_CD mum_NN )_) for_IN dry_JJ weight_NN measurement_NN ._SENT The_DT other_JJ 50_CD %_NN was_VBD kept_VBN in_IN dry_JJ ice_NN until_IN sonication_NN on_IN ice_NN (_( three_CD 30-s_JJ bursts_NNS ;_: amplitude_NN ,_, 6_CD mum_NN )_) ._SENT The_DT beta-lactamase_NN activity_NN was_VBD determined_VBN in_IN 10_CD mM_NP HEPES_NP buffer_NN (_( pH_NN 8.2_CD )_) and_CC at_IN 30C_JJ with_IN 115_CD muM_NN nitrocefin_NN as_IN a_DT substrate_NN ._SENT Determination_NN of_IN outer_JJ membrane_NN permeability_NN ._SENT |_SYM Cells_NP were_VBD grown_VBN overnight_RB in_IN Luria-Bertani_NP broth_NN containing_VBG kanamycin_NN or_CC tetracycline_NN (_( 50_CD mug/ml_NN )_) as_IN plasmid_NN selection_NN agents_NNS ._SENT The_DT resulting_VBG culture_NN was_VBD diluted_VBN 100-fold_NN into_IN the_DT appropriate_JJ culture_NN medium_NN without_IN any_DT isopropyl-beta-d-thiogalactopyranoside_NN or_CC antibiotic_NN ,_, and_CC growth_NN was_VBD resumed_VBN at_IN 37C_JJ up_RB to_TO an_DT A600_NP of_IN 1.5_CD ._SENT Cells_NNS were_VBD harvested_VBN by_IN centrifugation_NN at_IN 15_CD to_TO 20C_JJ and_CC resuspended_JJ in_IN the_DT appropriate_JJ prewarmed_JJ medium_NN ._SENT The_DT assay_NN was_VBD started_VBN 3_CD to_TO 5_CD min_NN after_IN equilibration_NN at_IN the_DT desired_VBN temperature_NN ._SENT A_DT sample_NN was_VBD also_RB taken_VBN for_IN dry_JJ weight_NN determination_NN ._SENT (_( i_NP )_) Determination_NN of_IN outer_JJ membrane_NN permeability_NN by_IN the_DT method_NN of_IN Zimmermann_NP and_CC Rosselet_NP ._SENT |_SYM A_DT portion_NN of_IN cell_NN suspension_NN (_( cell_NN density_NN [_SYM dry_JJ weight_NN ]_SYM between_IN 0.05_CD and_CC 0.15_CD mg/ml_NN )_) was_VBD sonicated_VBN on_IN ice_NN (_( three_CD 30-s_JJ bursts_NNS ;_: amplitude_NN ,_, 6_CD mum_NN )_) and_CC used_VBN for_IN determination_NN of_IN maximum_JJ rate_NN (_( Vmax_NP )_) ._SENT The_DT remaining_VBG part_NN of_IN the_DT intact_JJ cell_NN suspension_NN was_VBD mixed_VBN with_IN 400_CD to_TO 800_CD muM_NN cephacetrile_NN or_CC 250_CD to_TO 1,000_CD muM_NN cephaloridine_NN and_CC transferred_VBN to_TO a_DT cuvette_NN with_IN a_DT 1-mm_NP light_NN path_NN ,_, and_CC the_DT absorbance_NN at_IN 260_CD nm_NN was_VBD recorded_VBN with_IN the_DT help_NN of_IN an_DT Uvikon_NP 860_CD device_NN (_( Kontron_NP Instruments_NPS )_) ._SENT (_( ii_NP )_) Determination_NN of_IN outer_JJ membrane_NN permeability_NN by_IN the_DT new_JJ method_NN ._SENT (_( a_DT )_) Preliminary_JJ comment_NN ._SENT |_SYM The_DT protocol_NN described_VBD here_RB is_VBZ optimized_VBN for_IN 3H-_JJ or_CC 14C-labeled_JJ benzylpenicillin_NN and_CC [_SYM 14C]cephacetrile_JJ ._SENT However_RB ,_, it_PP can_MD probably_RB be_VB adapted_VBN according_VBG to_TO the_DT properties_NNS of_IN the_DT radiolabeled_JJ antibiotic_NN ._SENT Optimal_JJ results_NNS are_VBP obtained_VBN if_IN BlaR-CTD_JJ labeling_VBG can_MD be_VB quenched_VBN as_RB fast_RB as_IN possible_JJ and_CC if_IN the_DT excess_NN of_IN free_JJ antibiotic_NN can_MD be_VB almost_RB completely_RB removed_VBN ._SENT (_( b_LS )_) Determination_NN of_IN outer_JJ membrane_NN permeability_NN if_IN the_DT studied_VBN antibiotic_NN is_VBZ radiolabeled_VBN ._SENT |_SYM Nine_CD hundred_CD microliters_NNS of_IN cells_NNS (_( cell_NN density_NN [_SYM dry_JJ weight_NN ]_SYM ,_, 5_CD mg/ml_NN )_) in_IN the_DT appropriate_JJ prewarmed_JJ medium_NN was_VBD mixed_VBN with_IN 100_CD mul_NN of_IN prewarmed_JJ antibiotic_NN (_( 10_CD muM_NN [_SYM 3H]benzylpenicillin_NP [_SYM see_VB Fig._NN ]_SYM ;_: 4.5_CD to_TO 18_CD muM_NN [_SYM 14C]benzylpenicillin_NP [_SYM see_VB Fig._NN ]_SYM ;_: 1.5_CD muM_NN [_SYM 14C]cephacetrile_JJ )_) ._SENT Aliquots_NNS of_IN 100_CD mul_NN were_VBD withdrawn_VBN after_IN various_JJ intervals_NNS and_CC mixed_VBN to_TO 25_CD mul_NN of_IN 5_CD N_NP HCl_NP to_TO instantaneously_RB stop_VB the_DT binding_NN to_TO BlaR-CTD_NP ._SENT The_DT excess_NN of_IN free_JJ radiolabeled_JJ antibiotic_NN was_VBD eliminated_VBN by_IN three_CD extractions_NNS with_IN the_DT same_JJ volume_NN of_IN water-saturated_JJ butanol_NN ._SENT The_DT proteins_NNS were_VBD then_RB precipitated_VBN by_IN adding_VBG 25_CD mul_NN of_IN a_DT mixture_NN of_IN 50_CD %_NN trichloroacetic_JJ acid-3.75_NN %_NN tungstosilicic_JJ acid_NN (_( Fluka_NP ,_, Buchs_NP ,_, Switzerland_NP )_) ._SENT Samples_NNS were_VBD left_VBN on_IN ice_NN for_IN 10_CD min_NN and_CC then_RB centrifuged_VBD 45_CD min_NN at_IN 15,000_CD x_SYM g._FW The_DT supernatant_JJ was_VBD removed_VBN and_CC the_DT tubes_NNS were_VBD washed_VBN once_RB with_IN water_NN to_TO remove_VB the_DT last_JJ traces_NNS of_IN radiolabeled_JJ antibiotic_NN ._SENT After_IN centrifugation_NN ,_, the_DT pellet_NN was_VBD solubilized_VBN in_IN 10_CD %_NN SDS_NP and_CC the_DT radioactivity_NN was_VBD determined_VBN with_IN a_DT scintillation_NN counter_NN ._SENT (_( c_LS )_) Determination_NN of_IN outer_JJ membrane_NN permeability_NN if_IN the_DT studied_VBN antibiotic_NN is_VBZ not_RB radioactive_JJ ._SENT |_SYM If_IN the_DT studied_VBN antibiotic_NN is_VBZ not_RB radioactive_JJ ,_, the_DT unlabeled_JJ antibiotic_NN is_VBZ incubated_VBN at_IN 25C_JJ for_IN increasing_VBG periods_NNS of_IN time_NN in_IN a_DT total_JJ volume_NN of_IN 1_CD ml_NN of_IN the_DT cell_NN suspension_NN ._SENT The_DT residual_JJ free_JJ BlaR-CTD_NN is_VBZ then_RB counterlabeled_JJ with_IN 15_CD muM_NN [_SYM 14C]cephacetrile_JJ ._SENT This_DT labeled_VBN compound_NN was_VBD chosen_VBN for_IN its_PP$ high_JJ diffusion_NN coefficient_NN ._SENT Under_IN the_DT conditions_NNS described_VBD here_RB the_DT counterlabeling_NN is_VBZ completed_VBN within_IN 20_CD s._NN A_DT higher_JJR cell_NN density_NN was_VBD used_VBN because_IN of_IN the_DT lower_JJR specific_JJ radioactivity_NN of_IN the_DT counterlabeling_JJ antibiotic_NN ._SENT Nine_CD hundred_CD microliters_NNS of_IN cells_NNS (_( cell_NN density_NN [_SYM dry_JJ weight_NN ]_SYM ,_, 20_CD to_TO 30_CD mg/ml_NN )_) in_IN the_DT appropriate_JJ prewarmed_JJ medium_NN was_VBD mixed_VBN with_IN 100_CD mul_NN of_IN prewarmed_JJ nonradioactive_JJ antibiotic_NN ._SENT After_IN different_JJ time_NN intervals_NNS ,_, 100-mul_NP samples_NNS were_VBD removed_VBN and_CC added_VBN with_IN 50_CD mul_NN of_IN 45_CD muM_NN [_SYM 14C]cephacetrile_JJ ._SENT After_IN 2_CD min_NN of_IN incubation_NN at_IN 25C_NP ,_, the_DT reaction_NN was_VBD stopped_VBN and_CC the_DT samples_NNS were_VBD treated_VBN as_RB above_RB ._SENT The_DT antibiotic_JJ concentrations_NNS used_VBN for_IN permeability_NN measurements_NNS were_VBD as_RB follows_VBZ :_: 7.5_CD ,_, 15_CD ,_, and_CC 30_CD muM_NN cefotaxime_NN ;_: 50_CD ,_, 100_CD ,_, and_CC 200_CD muM_NN carbenicillin_NN ;_: 5_CD ,_, 10_CD ,_, and_CC 20_CD muM_NN ampicillin_NN ;_: and_CC 75_CD ,_, 100_CD ,_, and_CC 200_CD muM_NN aztreonam_NP ._SENT The_DT longest_JJS incubation_NN time_NN was_VBD 45_CD min_NN ._SENT Model_NN and_CC simulation_NN ._SENT |_SYM Using_VBG the_DT new_JJ method_NN ,_, the_DT situation_NN that_WDT prevails_VBZ during_IN the_DT measurement_NN of_IN the_DT outer_JJ membrane_NN permeability_NN for_IN a_DT beta-lactamase_NN producing_VBG strain_NN is_VBZ represented_VBN by_IN the_DT following_VBG model_NN :_: where_WRB Ie_NP represents_VBZ the_DT external_JJ concentration_NN of_IN antibiotic_NN ,_, Ip_NP represents_VBZ the_DT periplasmic_JJ concentration_NN of_IN antibiotic_NN ,_, E1_NP represents_VBZ the_DT periplasmic_JJ concentration_NN of_IN BlaR-CTD_NP ,_, E2_NP represents_VBZ the_DT periplasmic_JJ concentration_NN of_IN beta-lactamase_NN ,_, E1I*_NP and_CC E2I*_NP represent_VBP the_DT corresponding_JJ acyl_NN enzymes_NNS ,_, X_NP represents_VBZ the_DT degradation_NN product_NN of_IN I_PP (_( all_DT concentrations_NNS are_VBP micromolar_JJ concentrations_NNS )_) ,_, kd_NN represents_VBZ the_DT first-order_NN rate_NN constant_JJ for_IN antibiotic_JJ diffusion_NN through_IN the_DT outer_JJ membrane_NN (_( per_IN second_JJ )_) ,_, kf1_NN and_CC kf2_NN represent_VBP the_DT second-order_NN rate_NN constants_NNS for_IN the_DT formation_NN of_IN E1I*_NP and_CC E2I*_NP ,_, respectively_RB (_( per_IN micromolar_NN per_IN second_JJ )_) ,_, and_CC k3_NN represents_VBZ the_DT first-order_NN rate_NN constant_JJ for_IN deacylation_NN of_IN the_DT beta-lactamase_NN (_( per_IN second_JJ )_) ._SENT The_DT equations_NNS describing_VBG the_DT variations_NNS of_IN Ip_NP ,_, E1I*_NP ,_, and_CC E2I*_NP are_VBP Simulations_NNS were_VBD performed_VBN on_IN the_DT basis_NN of_IN these_DT equations_NNS with_IN the_DT help_NN of_IN a_DT numerical_JJ integration_NN program_NN based_VBN on_IN a_DT Runge_NP Kutta_NP method_NN of_IN the_DT fourth_JJ order_NN ._SENT For_IN beta-lactamase-deficient_JJ strains_NNS ,_, the_DT same_JJ model_NN was_VBD used_VBN with_IN [_SYM E2_NP ]_SYM and_CC [_SYM E2I*_NP ]_SYM equal_JJ to_TO zero_CD ._SENT Calculation_NN of_IN the_DT permeability_NN coefficient_NN (_( P_NN )_) by_IN the_DT new_JJ method_NN ._SENT |_SYM Since_IN kd_NN is_VBZ equal_JJ to_TO PA/Vp_NP and_NP [_SYM E1I*_NP ]_SYM is_VBZ equal_JJ to_TO nE1I*/Vp_NN ,_, where_WRB Vp_NP is_VBZ the_DT periplasmic_JJ volume_NN and_CC nE1I*_NN is_VBZ the_DT quantity_NN of_IN labeled_VBN BlaR-CTD_NN (_( in_IN picomoles_NNS )_) A_DT is_VBZ equal_JJ to_TO 132_CD cm2_NN mg_NN (_( dry_JJ weight)-1_NN ,_, and_CC the_DT unit_NN for_IN [_SYM Ie_NP ]_SYM is_VBZ nanomolar_JJ ._SENT d(nE1I*)/dt_NP can_MD be_VB obtained_VBN by_IN multiplying_VBG the_DT slope_NN of_IN the_DT observed_JJ labeling_VBG versus_IN time_NN (_( expressed_VBN in_IN counts_NNS per_IN minute_JJ second-1_JJ milligram_NN [_SYM dry_JJ weight]-1_NN )_) by_IN the_DT specific_JJ activity_NN of_IN the_DT labeled_VBN antibiotic_NN (_( 0.0096_CD pmol_NN cpm-1_JJ for_IN [_SYM 14C]benzylpenicillin_NP and_CC 0.123_CD pmol_NN cpm-1_JJ for_IN [_SYM 14C]cephacetrile_JJ as_IN estimated_JJ using_VBG [_SYM 14C]hexadecane_NP [_SYM 1.1_CD muCi/g_NN ]_SYM as_IN a_DT standard_NN for_IN estimating_VBG the_DT counting_VBG yield_NN )_) ._SENT Validity_NN of_IN the_DT new_JJ method_NN ._SENT |_SYM Zimmermann_NP was_VBD the_DT first_JJ to_TO use_VB the_DT rate_NN of_IN PBP_NP acylation_NN for_IN a_DT qualitative_JJ evaluation_NN of_IN outer_JJ membrane_NN permeability_NN ._SENT However_RB ,_, as_RB pointed_VBD out_RP by_IN Nikaido_NP ,_, the_DT method_NN is_VBZ valid_JJ only_RB if_IN the_DT periplasmic_JJ concentration_NN of_IN the_DT beta-lactam_NN has_VBZ not_RB reached_VBN its_PP$ equilibrium_NN value_NN ,_, i.e._FW ,_, if_IN the_DT reaction_NN of_IN the_DT beta-lactam_NN with_IN the_DT PBP_NP is_VBZ more_RBR rapid_JJ than_IN the_DT diffusion_NN process_NN ._SENT Using_VBG the_DT above_JJ model_NN for_IN a_DT beta-lactamase-deficient_JJ strain_NN ,_, we_PP have_VBP searched_VBN for_IN combinations_NNS of_IN kf1_NN ,_, kd_NNS ,_, E1_JJ total_JJ concentration_NN (_( E1tot_NP )_) and_CC Ie_NP which_WDT result_VBP in_IN rate-limiting_JJ diffusion_NN under_IN these_DT conditions_NNS :_: Simulations_NNS were_VBD done_VBN keeping_VBG E1tot_NP between_IN 10_CD and_CC 40_CD muM_NN ,_, Ie_NP between_IN 0.5_CD and_CC 100_CD muM_NN ,_, and_CC kd_NNS at_IN <0.26_JJ s-1_NN ._SENT In_IN all_DT cases_NNS the_DT acylation_NN of_IN E1_NP up_RB to_TO 70_CD %_NN saturation_NN (_( E1I*/E1tot_NP =_SYM 0.7_CD )_) was_VBD analyzed_VBN by_IN linear_JJ regression_NN ._SENT The_DT kd_NN values_NNS calculated_VBN on_IN the_DT basis_NN of_IN equation_NN 2_CD were_VBD then_RB compared_VBN to_TO those_DT used_VBN in_IN the_DT simulation_NN ._SENT From_IN these_DT analyses_NNS (_( data_NNS not_RB shown_VBN )_) ,_, it_PP appears_VBZ that_IN diffusion_NN can_MD be_VB considered_VBN limiting_VBG if_IN This_DT relation_NN gives_VBZ useful_JJ information_NN on_IN the_DT limitations_NNS of_IN the_DT method_NN ._SENT For_IN example_NN ,_, it_PP will_MD be_VB difficult_JJ to_TO study_VB the_DT outer_JJ membrane_NN permeability_NN of_IN E._NP coli_NNS because_IN most_JJS of_IN its_PP$ kd_NN values_NNS are_VBP larger_JJR than_IN 0.13_CD s-1_NN ,_, and_CC on_IN the_DT basis_NN of_IN equation_NN 3_CD ,_, it_PP would_MD thus_RB be_VB necessary_JJ to_TO produce_VB a_DT periplasmic_JJ PBP_NN with_IN kf_NN values_NNS larger_JJR than_IN 30,000_CD M-1_JJ s-1_NN (_( if_IN we_PP assume_VBP E1tot_NP =_SYM 40_CD muM_NN )_) ._SENT On_IN the_DT contrary_NN ,_, this_DT method_NN applies_VBZ well_RB to_TO P._NP aeruginosa_NP because_IN all_DT reported_VBN kd_NN values_NNS are_VBP below_RB 0.13_CD s-1_NN ._SENT BlaR-CTD_NP is_VBZ therefore_RB an_DT ideal_JJ PBP_NN for_IN such_JJ studies_NNS ,_, because_IN the_DT kf_NN values_NNS for_IN various_JJ beta-lactams_NNS are_VBP between_IN 103_CD and_CC 106_CD M-1_JJ s-1_NN (_( Swinnen_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT Note_NN that_IN if_IN the_DT value_NN of_IN kf1_NN for_IN the_DT studied_VBN compound_NN is_VBZ not_RB known_VBN ,_, it_PP can_MD be_VB easily_RB measured_VBN to_TO demonstrate_VB that_DT diffusion_NN is_VBZ the_DT rate-limiting_JJ factor_NN (_( equation_NN 3_CD )_) ._SENT beta-Lactamase_NN production_NN is_VBZ another_DT important_JJ factor_NN ,_, as_IN these_DT enzymes_NNS compete_VBP with_IN PBPs_NNS for_IN the_DT free_JJ antibiotic_NN ._SENT Consequently_RB this_DT method_NN is_VBZ not_RB applicable_JJ to_TO beta-lactamase-overproducing_NN strains_NNS ._SENT For_IN beta-lactamase-inducible_JJ strains_NNS ,_, which_WDT produce_VBP low_JJ levels_NNS of_IN enzyme_NN in_IN the_DT noninduced_JJ state_NN ,_, the_DT validity_NN of_IN the_DT method_NN will_MD depend_VB on_IN (_( i_NP )_) the_DT relative_JJ concentration_NN of_IN the_DT two_CD enzymes_NNS ,_, (_( ii_NNS )_) their_PP$ relative_JJ affinity_NN for_IN the_DT antibiotic_NN ,_, and_CC (_( iii_NNS )_) the_DT stability_NN of_IN the_DT beta-lactam_NN against_IN hydrolysis_NN ._SENT Development_NN of_IN the_DT method_NN ._SENT |_SYM Because_IN some_DT beta-lactams_NNS might_MD cross_VB the_DT cytoplasmic_JJ membrane_NN ,_, the_DT cellular_JJ localization_NN of_IN BlaR-CTD_NP was_VBD analyzed_VBN ._SENT Periplasmic_JJ and_CC cellular_JJ fractions_NNS were_VBD added_VBN with_IN 5'-Flu-Gly-6APA_NP ,_, and_CC the_DT labeling_VBG was_VBD assessed_VBN under_IN UV_NP after_IN SDS-PAGE_NP ._SENT As_IN expected_VBN from_IN the_DT plasmid_NP construction_NN ,_, more_JJR than_IN 95_CD %_NN of_IN BlaR-CTD_NP is_VBZ found_VBN in_IN the_DT periplasm_NN ,_, and_CC only_RB a_DT small_JJ amount_NN of_IN precursor_NN is_VBZ detected_VBN in_IN the_DT cellular_JJ fraction_NN (_( result_NN not_RB shown_VBN )_) ._SENT The_DT influence_NN of_IN antibiotics_NNS on_IN outer_JJ membrane_NN integrity_NN is_VBZ still_RB largely_RB unknown_JJ ,_, and_CC therefore_RB fresh_JJ cultures_NNS were_VBD grown_VBN without_IN selective_JJ pressure_NN ._SENT Under_IN these_DT conditions_NNS ,_, 5_CD to_TO 15_CD %_NN of_IN cells_NNS lose_VBP their_PP$ plasmid_NN ._SENT Although_IN these_DT cells_NNS influence_VBP the_DT dry_JJ weight_NN but_CC do_VBP not_RB participate_VB in_IN the_DT permeability_NN measurement_NN ,_, no_DT correction_NN was_VBD introduced_VBN when_WRB calculating_JJ kd_NNS ._SENT Incubation_NN of_IN E._NP aerogenes_NNS 008-4_CD intact_JJ cells_NNS with_IN [_SYM 3H]benzylpenicillin_JJ shows_NNS that_IN they_PP bind_VBP more_JJR beta-lactam_NN if_IN they_PP express_VBP BlaR-CTD_NN ._SENT Some_DT protein-bound_JJ radioactivity_NN is_VBZ released_VBN into_IN the_DT medium_NN during_IN the_DT assay_NN ,_, but_CC it_PP only_RB represents_VBZ a_DT small_JJ percentage_NN of_IN the_DT cell-bound_JJ counts_NNS and_CC is_VBZ not_RB expected_VBN to_TO influence_VB the_DT slope_NN of_IN the_DT line_NN over_IN the_DT first_JJ 15_CD min_NN ._SENT The_DT binding_NN appears_VBZ to_TO be_VB a_DT three-step_NN process_NN ._SENT First_RB ,_, a_DT rapid_JJ step_NN of_IN small_JJ amplitude_NN occurs_VBZ during_IN the_DT mixing_VBG time_NN (_( i.e._FW ,_, t_NN =_SYM 0_CD [_SYM 5_CD to_TO 10_CD s_NNS in_IN Fig._NN ]_SYM )_) ,_, followed_VBN by_IN a_DT second_JJ step_NN of_IN larger_JJR amplitude_NN over_IN a_DT 15-min_JJ time_NN scale_NN and_CC finally_RB a_DT third_JJ step_NN with_IN a_DT small_JJ amplitude_NN on_IN a_DT larger_JJR time_NN scale_NN ._SENT The_DT same_JJ experiment_NN analyzed_VBN by_IN fluorography_NN shows_VBZ that_IN during_IN the_DT first_JJ 15_CD min_NN ,_, when_WRB the_DT highest_JJS binding_JJ rate_NN is_VBZ observed_JJ ,_, only_JJ BlaR-CTD_NN is_VBZ acylated_JJ ._SENT Acylation_NN of_IN the_DT membrane-bound_JJ PBPs_NP only_RB takes_VBZ place_NN during_IN the_DT third_JJ step_NN of_IN the_DT experiment_NN when_WRB BlaR_NP is_VBZ fully_RB labeled_VBN ._SENT Because_IN the_DT total_JJ amount_NN of_IN BlaR-CTD_NP is_VBZ constant_JJ during_IN the_DT experiment_NN and_CC no_DT significant_JJ release_NN into_IN the_DT medium_NN occurs_VBZ during_IN that_DT time_NN ,_, the_DT labeling_VBG observed_JJ over_IN the_DT first_JJ 15_CD min_NN after_IN mixing_VBG is_VBZ diffusion_NN dependent_JJ and_CC can_MD be_VB used_VBN to_TO measure_VB the_DT outer_JJ membrane_NN permeability_NN ._SENT The_DT binding_NN which_WDT occurs_VBZ during_IN the_DT mixing_VBG time_NN remains_VBZ unexplained_JJ ,_, since_IN in_IN the_DT case_NN of_IN E._NP aerogenes_NNS 008-4_CD devoid_JJ of_IN plasmid_NP ,_, no_DT labeled_VBN protein_NN is_VBZ detected_VBN when_WRB samples_NNS are_VBP directly_RB denatured_VBN and_CC analyzed_VBN by_IN SDS-PAGE_NP ._SENT This_DT labeling_VBG is_VBZ probably_RB due_JJ to_TO nonspecific_JJ adsorption_NN or_CC trapping_VBG of_IN the_DT antibiotic_NN because_IN of_IN the_DT high_JJ cell_NN density_NN and_CC acidic_JJ treatment_NN ._SENT When_WRB pDML310_NN is_VBZ present_JJ in_IN the_DT cells_NNS ,_, in_IN addition_NN to_TO this_DT phenomenon_NN ,_, some_DT BlaR-CTD_NN might_MD be_VB freely_RB accessible_JJ because_IN it_PP is_VBZ inserted_VBN into_IN the_DT outer_JJ membrane_NN with_IN its_PP$ active_JJ site_NN directed_VBN to_TO the_DT medium_NN ,_, as_RB already_RB observed_VBN with_IN beta-lactamases_NNS ._SENT Moreover_RB ,_, whatever_WDT its_PP$ cause_NN ,_, this_DT phenomenon_NN does_VBZ not_RB alter_VB the_DT linearity_NN of_IN BlaR-CTD_NN labeling_VBG during_IN the_DT second_JJ phase_NN ._SENT For_IN the_DT cells_NNS which_WDT do_VBP not_RB produce_VB BlaR-CTD_NP ,_, the_DT slow_JJ labeling_VBG is_VBZ due_JJ to_TO the_DT membrane_NN bound_VBN PBPs_NP ._SENT The_DT method_NN was_VBD applied_VBN to_TO measure_VB the_DT outer_JJ membrane_NN permeability_NN of_IN E._NP aerogenes_NNS 008-4_CD to_TO [_SYM 14C]benzylpenicillin_NP ._SENT As_IN illustrated_VBN by_IN Fig._NN ,_, during_IN the_DT second_JJ phase_NN ,_, the_DT labeling_VBG rate_NN increases_NNS in_IN proportion_NN with_IN the_DT external_JJ antibiotic_JJ concentration_NN ._SENT The_DT permeability_NN coefficient_NN calculated_VBN from_IN the_DT slopes_NNS using_VBG equation_NN 1_CD is_VBZ (_( 2.7_CD +-_NN 0.5_CD )_) x_SYM 10-8_CD cm/s_NNS ._SENT Using_VBG the_DT same_JJ method_NN ,_, we_PP have_VBP measured_VBN the_DT permeability_NN coefficient_NN of_IN [_SYM 14C]cephacetrile_JJ ._SENT As_IN expected_VBN from_IN previous_JJ work_NN ,_, its_PP$ diffusion_NN rate_NN is_VBZ about_RB 2_CD orders_NNS of_IN magnitude_NN higher_JJR than_IN that_IN of_IN benzylpenicillin_NN and_CC is_VBZ equal_JJ to_TO (_( 1.8_CD +-_NN 0.3_CD )_) x_SYM 10-6_CD cm/s_NNS and_CC (_( 4.2_CD +-_NN 0.8_CD )_) x_SYM 10-6_CD cm/s_NNS for_IN E._NP aerogenes_NNS 008-4_CD and_CC E._NP cloacae_NNS AD2_NP ,_, respectively_RB ._SENT Because_IN our_PP$ method_NN is_VBZ expected_VBN to_TO be_VB less_RBR accurate_JJ for_IN high_JJ P_NN values_NNS ,_, its_PP$ validity_NN was_VBD tested_VBN by_IN measuring_VBG the_DT permeability_NN of_IN E._NP cloacae_NNS 908R_NN to_TO cephacetrile_NN with_IN the_DT help_NN of_IN the_DT method_NN of_IN Zimmermann_NP and_CC Rosselet_NP ._SENT Using_VBG the_DT kinetic_JJ parameters_NNS of_IN E._NP cloacae_NNS P99_NP beta-lactamase_NN ,_, the_DT P_NN value_NN was_VBD estimated_VBN at_IN about_IN (_( 5.2_CD +-_NN 0.4_CD )_) x_SYM 10-6_CD cm/s_NNS ,_, a_DT value_NN not_RB significantly_RB larger_JJR than_IN that_DT measured_VBN by_IN the_DT new_JJ method_NN ._SENT For_IN unlabeled_JJ antibiotics_NNS ,_, the_DT method_NN is_VBZ only_RB applicable_JJ by_IN counterlabeling_VBG with_IN a_DT radioactive_JJ compound_NN ._SENT Of_IN course_NN ,_, the_DT result_NN is_VBZ only_RB valid_JJ if_IN the_DT diffusion_NN rate_NN of_IN the_DT labeled_VBN antibiotic_NN (_( i.e._FW ,_, kd_NNS [_SYM Ie_NP ]_SYM )_) is_VBZ at_IN least_JJS 10_CD times_NNS larger_JJR than_IN that_DT of_IN the_DT unlabeled_JJ beta-lactam_NN ._SENT Due_JJ to_TO its_PP$ high_JJ P_NN value_NN ,_, cephacetrile_NN is_VBZ adequate_JJ in_IN this_DT case_NN ._SENT Using_VBG the_DT counterlabeling_JJ method_NN with_IN [_SYM 14C]cephacetrile_JJ ,_, the_DT P_NN value_NN of_IN E._NP aerogenes_NNS 008-4_CD for_IN benzylpenicillin_NN was_VBD found_VBN to_TO be_VB 3.1_CD x_SYM 10-8_CD cm/s_NNS ._SENT This_DT value_NN is_VBZ close_JJ to_TO that_DT measured_VBN directly_RB with_IN radiolabeled_JJ benzylpenicillin_NN ,_, demonstrating_VBG that_IN counterlabeling_VBG with_IN cephacetrile_NN is_VBZ accurate_JJ ._SENT Therefore_RB ,_, the_DT permeability_NN coefficients_NNS of_IN E._NP aerogenes_NNS 008-4_CD and_CC E._NP cloacae_NNS AD2_NP for_IN ampicillin_NP ,_, carbenicillin_NP ,_, cefotaxime_NN and_CC aztreonam_NP were_VBD measured_VBN at_IN 25C_JJ (_( Fig._NN ;_: Table_NP )_) ._SENT In_IN all_DT cases_NNS ,_, the_DT outer_JJ membrane_NN permeability_NN of_IN E._NP aerogenes_NNS is_VBZ lower_JJR than_IN that_DT of_IN E._NP cloacae_NNS by_IN a_DT factor_NN of_IN about_RB 2_CD ._SENT Application_NN to_TO wild-type_NN beta-lactamase-producing_NN strains_NNS ._SENT |_SYM As_RB mentioned_VBN before_RB ,_, the_DT presence_NN of_IN a_DT periplasmic_JJ beta-lactamase_NN can_MD be_VB an_DT important_JJ limiting_VBG factor_NN for_IN the_DT method_NN ._SENT Using_VBG experimental_JJ values_NNS obtained_VBN with_IN P._NP aeruginosa_NP PAO1_NP and_CC the_DT mean_JJ P_NN of_IN Enterobacter_NP for_IN benzylpenicillin_NN ,_, simulations_NNS were_VBD performed_VBN to_TO see_VB if_IN a_DT low_JJ amount_NN of_IN class_NN C_NP beta-lactamase_NN as_RB encountered_VBD in_IN wild-type_NN strains_NNS could_MD impair_VB benzylpenicillin_NN permeability_NN measurements_NNS ._SENT On_IN the_DT basis_NN of_IN the_DT beta-lactamase_NN activity_NN in_IN a_DT total_JJ cell_NN lysate_NN of_IN PAO1_NP ,_, a_DT periplasmic_JJ enzyme_NN concentration_NN of_IN 0.09_CD muM_NN was_VBD estimated_VBN ._SENT Table_NN shows_VBZ that_IN BlaR-CTD_NP is_VBZ acylated_JJ even_RB in_IN the_DT presence_NN of_IN a_DT low_JJ amount_NN of_IN class_NN C_NP beta-lactamase_NN ._SENT On_IN the_DT basis_NN of_IN the_DT simulated_JJ acylation_NN rate_NN (_( 23_CD muM_NN in_IN 120_CD s_NNS )_) ,_, the_DT calculated_JJ kd_NN was_VBD 6.3_CD x_SYM 10-3_CD s-1_NN ,_, which_WDT is_VBZ only_RB 5_CD %_NN lower_JJR than_IN that_DT used_VBN in_IN the_DT simulation_NN ._SENT We_PP therefore_RB measured_VBD the_DT outer_JJ membrane_NN permeability_NN of_IN two_CD wild-type_NN strains_NNS producing_VBG low_JJ levels_NNS of_IN inducible_JJ beta-lactamase_NN ._SENT The_DT measured_VBN P_NN for_IN E._NP aerogenes_NNS 006_CD to_TO [_SYM 14C]benzylpenicillin_NN was_VBD 2.4_CD +-_NN 0.5_CD x_SYM 10-8_CD cm/s_NNS ._SENT When_WRB the_DT method_NN was_VBD applied_VBN to_TO P._NP aeruginosa_NP PAO1_NP ,_, a_DT P_NN of_IN 1.3_CD +-_NN 0.25_CD x_SYM 10-8_CD cm/s_NNS was_VBD obtained_VBN for_IN benzylpenicillin_NN ._SENT In_IN these_DT two_CD experiments_NNS ,_, less_JJR than_IN 30_CD %_NN of_IN the_DT beta-lactam_NN was_VBD hydrolyzed_VBN during_IN the_DT experiment_NN as_IN shown_VBN by_IN thin-layer_JJ chromatography_NN analysis_NN ._SENT Until_IN now_RB ,_, the_DT only_JJ method_NN allowing_VBG a_DT direct_JJ quantitative_JJ measurement_NN of_IN the_DT outer_JJ membrane_NN permeability_NN was_VBD that_IN of_IN Zimmermann_NP and_CC Rosselet_NP ._SENT Although_IN there_EX have_VBP been_VBN some_DT technical_JJ improvements_NNS to_TO this_DT method_NN ,_, it_PP still_RB remains_VBZ inaccurate_JJ to_TO measure_VB low_JJ permeability_NN values_VBZ when_WRB freely_RB accessible_JJ beta-lactamase_NN is_VBZ present_JJ in_IN the_DT medium_NN or_CC on_IN the_DT cell_NN surface_NN ._SENT The_DT new_JJ method_NN described_VBN in_IN this_DT paper_NN uses_VBZ a_DT periplasmic_JJ PBP_NN which_WDT exhibits_VBZ a_DT high_JJ affinity_NN for_IN beta-lactams_NNS and_CC is_VBZ best_RBS suited_VBN for_IN the_DT measurement_NN of_IN low_JJ outer_JJ membrane_NN permeability_NN values_NNS ._SENT Indeed_RB ,_, equation_NN 2_CD is_VBZ only_RB valid_JJ when_WRB the_DT diffusion_NN process_NN is_VBZ rate_NN limiting_VBG ,_, a_DT condition_NN more_RBR easily_RB fulfilled_VBN when_WRB P_NN is_VBZ low_JJ ._SENT Under_IN our_PP$ conditions_NNS ,_, and_CC as_RB shown_VBN by_IN Fig._NN ,_, only_JJ BlaR-CTD_NN was_VBD significantly_RB labeled_VBN ._SENT Interference_NN by_IN another_DT PBP_NP would_MD require_VB a_DT rapidly_RB reacting_VBG ,_, overproduced_VBD ,_, readily_RB accessible_JJ protein_NN ,_, a_DT situation_NN which_WDT ,_, to_TO our_PP$ knowledge_NN ,_, has_VBZ never_RB been_VBN encountered_VBN ._SENT Another_DT advantage_NN is_VBZ that_IN experiments_NNS can_MD be_VB performed_VBN even_RB in_IN complex_JJ solutions_NNS such_JJ as_IN culture_NN media_NNS ._SENT This_DT is_VBZ important_JJ since_IN various_JJ experiments_NNS have_VBP demonstrated_VBN that_IN pH_NN and_CC Donnan_NP potential_NN can_MD modify_VB the_DT P_NN for_IN various_JJ beta-lactams_NNS ._SENT By_IN our_PP$ method_NN ,_, we_PP have_VBP measured_VBN the_DT outer_JJ membrane_NN P_NN values_NNS for_IN two_CD Enterobacter_NP strains_NNS and_CC six_CD antibiotics_NNS ._SENT It_PP should_MD be_VB noted_VBN that_IN whatever_WDT the_DT species_NN ,_, P_NN values_NNS for_IN benzylpenicillin_NN ,_, ampicillin_NP ,_, carbenicillin_NN ,_, and_CC aztreonam_NP had_VBD never_RB been_VBN measured_VBN on_IN whole_JJ cells_NNS ._SENT As_IN shown_VBN in_IN Table_NP ,_, with_IN the_DT exception_NN of_IN cephaloridine_NN and_CC cephacetrile_NN ,_, the_DT P_NN values_NNS do_VBP not_RB exceed_VB 10-7_CD cm/s_NNS ._SENT Also_RB note_VBP that_IN the_DT permeability_NN for_IN aztreonam_NP is_VBZ the_DT lowest_JJS ever_RB measured_VBN and_CC this_DT antibiotic_NN is_VBZ the_DT only_JJ one_CD for_IN which_WDT the_DT half-equilibration_NN times_NNS are_VBP larger_JJR than_IN the_DT generation_NN times_NNS of_IN the_DT bacteria_NNS ._SENT This_DT very_RB low_JJ diffusion_NN rate_NN can_MD also_RB invalidate_VB the_DT method_NN of_IN Zimmermann_NP and_CC Rosselet_NP ,_, since_IN the_DT steady-state_NN assumption_NN is_VBZ not_RB verified_VBN ._SENT It_PP also_RB appears_VBZ that_IN the_DT outer_JJ membrane_NN of_IN E._NP cloacae_NNS is_VBZ two-_NN to_TO threefold_RB more_RBR permeable_JJ than_IN that_DT of_IN E._NP aerogenes_NNS ,_, and_CC as_RB reported_VBN for_IN other_JJ Enterobacter_NP species_NNS ,_, P_NN values_NNS are_VBP lower_JJR than_IN those_DT of_IN E._NP coli_NNS ._SENT For_IN cephaloridine_NN ,_, cephacetrile_NN ,_, carbenicillin_NN ,_, and_CC benzylpenicillin_NN ,_, E._NP cloacae_NNS AD2_NP is_VBZ 20-to_JJ 60-fold_NN less_RBR permeable_JJ than_IN E._NP coli_NNS SNO3_NP ._SENT For_IN cefotaxime_NN ,_, aztreonam_NP ,_, and_CC ampicillin_NP ,_, E._NP cloacae_NNS AD2_NN is_VBZ ,_, respectively_RB ,_, 400-_CD ,_, 1,000-_CD ,_, and_CC 700-fold_NNS less_RBR permeable_JJ than_IN E._NP coli_NNS ._SENT In_IN decreasing_VBG order_NN of_IN permeation_NN rate_NN ,_, the_DT classification_NN for_IN E._NP cloacae_NNS is_VBZ cephaloridine_JJ ,_, cephacetrile_NN ,_, ampicillin_NP ,_, benzylpenicillin_NN ,_, cefotaxime_NN ,_, carbenicillin_NN ,_, and_CC aztreonam_NP ._SENT These_DT results_NNS suggest_VBP that_IN the_DT porins_NNS of_IN these_DT Enterobacter_NP strains_NNS have_VBP a_DT different_JJ selectivity_NN compared_VBN to_TO those_DT of_IN E._NP coli_NNS ._SENT They_PP seem_VBP to_TO be_VB more_RBR restrictive_JJ and/or_CC more_RBR affected_JJ by_IN the_DT drug_NN structure_NN ._SENT Note_NN that_IN the_DT only_RB obvious_JJ common_JJ characteristic_NN of_IN ampicillin_NN ,_, cefotaxime_NN ,_, and_CC aztreonam_NP ,_, the_DT compounds_NNS for_IN which_WDT the_DT largest_JJS difference_NN is_VBZ observed_VBN between_IN E._NP coli_NNS and_CC Enterobacter_NP ,_, is_VBZ the_DT presence_NN of_IN a_DT free_JJ amine_NN on_IN the_DT side_NN chain_NN (_( in_IN C-6_NP for_IN the_DT penam_NP ,_, C-7_JJ for_IN the_DT cephem_NN ,_, and_CC C3_NP for_IN the_DT monobactam_NN )_) ._SENT Whether_IN or_CC not_RB this_DT could_MD influence_VB the_DT diffusion_NN through_IN Enterobacter_NP porins_NNS remains_VBZ to_TO be_VB established_VBN or_CC confirmed_VBN ._SENT A_DT similar_JJ wider_JJR dispersion_NN of_IN the_DT P_NN values_NNS in_IN Serratia_NP marcescens_NNS when_WRB compared_VBN to_TO E._NP coli_NNS has_VBZ been_VBN reported_VBN by_IN Raimondi_NP et_FW al._FW ._SENT At_IN 37C_JJ ,_, the_DT P_NN value_NN of_IN E._NP cloacae_NNS AD2_JJ for_IN benzylpenicillin_NN does_VBZ not_RB significantly_RB increase_VB when_WRB compared_VBN to_TO that_DT at_IN 25C_JJ ,_, whereas_IN for_IN E._NP aerogenes_NNS 008-4_CD and_CC cefotaxime_NN ,_, benzylpenicillin_NN ,_, and_CC aztreonam_NP ,_, these_DT values_NNS increase_NN by_IN factors_NNS of_IN 1.8_CD ,_, 2.4_CD ,_, and_CC 3.5_CD ,_, respectively_RB (_( data_NNS not_RB shown_VBN )_) ._SENT Consequently_RB it_PP appears_VBZ that_IN the_DT studied_VBN beta-lactams_NNS mostly_RB cross_VBP the_DT outer_JJ membrane_NN through_IN porins_NNS ._SENT Because_IN the_DT measured_VBN diffusion_NN rates_NNS are_VBP very_RB low_JJ ,_, one_PP can_MD wonder_VB if_IN active_JJ efflux_NN mechanisms_NNS impair_VBP the_DT measurement_NN of_IN the_DT P_NN values_NNS ._SENT The_DT two_CD beta-lactamase-deficient_JJ strains_NNS studied_VBD here_RB are_VBP derived_VBN from_IN beta-lactamase_NN overproducing_VBG strains_NNS obtained_VBN by_IN a_DT multistep_NN selection_NN process_NN ._SENT Based_VBN on_IN recent_JJ results_NNS ,_, one_PP might_MD suppose_VB that_IN these_DT four_CD strains_NNS possess_VBP an_DT increased_VBN efflux_NN activity_NN that_WDT can_MD compete_VB with_IN BlaR-CTD_NN for_IN the_DT periplasmic_JJ beta-lactam_NN ._SENT Various_JJ data_NNS do_VBP not_RB favor_VB this_DT hypothesis_NN ._SENT First_RB ,_, E._NP cloacae_NNS 908S_NNS (_( the_DT wild-type_NN beta-lactamase-inducible_JJ strain_NN )_) and_CC E._NP cloacae_NNS 908R_NN (_( the_DT beta-lactamase-overproducing_NN strain_NN )_) show_VBP the_DT same_JJ level_NN of_IN resistance_NN to_TO various_JJ non-beta-lactam_NN antibiotics_NNS such_JJ as_IN chloramphenicol_NN ,_, norfloxacin_NP ,_, nalidixic_JJ acid_NN ,_, or_CC erythromycin_NN ,_, and_CC these_DT levels_NNS are_VBP the_DT same_JJ as_IN those_DT observed_VBN for_IN Salmonella_NP wild-type_NN strains_NNS ._SENT Moreover_RB ,_, the_DT P_NN for_IN benzylpenicillin_NN ,_, a_DT beta-lactam_NN sensitive_JJ to_TO efflux_NN systems_NNS ,_, is_VBZ the_DT same_JJ for_IN E._NP aerogenes_NNS 006_CD ,_, the_DT wild-type_NN strain_NN ,_, and_CC E._NP aerogenes_NNS 008-4_CD ._SENT Therefore_RB ,_, the_DT efflux_NN activity_NN of_IN the_DT beta-lactamase-deficient_NN and_CC -overproducing_NN strains_NNS used_VBN in_IN this_DT study_NN is_VBZ not_RB significantly_RB different_JJ from_IN that_DT of_IN the_DT wild-type_NN strains_NNS ._SENT To_TO demonstrate_VB that_IN ,_, in_IN the_DT cases_NNS we_PP studied_VBD ,_, the_DT basal_JJ efflux_NN system_NN does_VBZ not_RB interfere_VB with_IN the_DT method_NN ,_, we_PP have_VBP tried_VBN to_TO predict_VB the_DT MICs_NN for_IN the_DT beta-lactamase-overproducing_NN strains_NNS on_IN the_DT basis_NN of_IN the_DT following_VBG equation_NN :_: MIC_NP =_SYM Ipl_NP +_SYM VmaxIpl/[PA_NP (_( Km_NP +_SYM Ipl_NN )_) ]_SYM ._SENT Because_IN its_PP$ beta-lactamase_NN is_VBZ still_RB partially_RB inducible_JJ (_( data_NNS not_RB shown_VBN )_) ,_, the_DT prediction_NN was_VBD not_RB done_VBN with_IN E._NP aerogenes_NNS 008_CD ._SENT In_IN Table_NP ,_, the_DT lethal_JJ periplasmic_JJ concentration_NN of_IN beta-lactam_NP (_( Ipl_NP )_) is_VBZ the_DT MIC_NN for_IN E._NP cloacae_NNS AD2_NP ._SENT These_DT values_NNS are_VBP higher_JJR than_IN expected_VBN on_IN the_DT basis_NN of_IN the_DT PBP_NP sensitivity_NN ,_, but_CC as_RB discussed_VBN previously_RB ,_, except_IN for_IN cephaloridine_NN ,_, this_DT has_VBZ little_JJ impact_NN on_IN the_DT MICs_NP for_IN E._NP cloacae_NNS 908R_NN ,_, because_IN they_PP are_VBP much_RB larger_JJR than_IN the_DT corresponding_JJ Kms_NP ,_, and_CC therefore_RB the_DT VmaxIpl/PA_NP (_( Km_NP +_SYM Ipl_NN )_) term_NN simplifies_VBZ to_TO Vmax/PA_NP ._SENT This_DT "_`` abnormal_JJ "_'' resistance_NN of_IN E._NP cloacae_NNS AD2_NP probably_RB results_VBZ from_IN an_DT efflux_NN system_NN naturally_RB expressed_VBD in_IN this_DT strain_NN or_CC from_IN the_DT selection_NN of_IN a_DT mutant_NN overproducing_VBG an_DT efflux_NN system_NN during_IN MIC_JJ measurements_NNS ._SENT How_WRB ever_RB ,_, while_IN efflux_NN certainly_RB contributes_VBZ to_TO increase_VB the_DT MICs_NP for_IN AD2_NP ,_, it_PP is_VBZ unlikely_JJ to_TO affect_VB the_DT beta-lactam_NN resistance_NN of_IN 908R_NN (_( compare_VB the_DT MICs_NN for_IN the_DT isogenic_JJ AD2_NN and_CC 908R_NN strains_NNS )_) ._SENT If_IN efflux_NN was_VBD interfering_VBG with_IN P_NN measurement_NN ,_, it_PP would_MD certainly_RB decrease_VB the_DT periplasmic_JJ concentration_NN of_IN antibiotic_JJ and_CC thus_RB the_DT rate_NN of_IN BlaR-CTD_JJ acylation_NN ._SENT This_DT would_MD result_VB in_IN underestimated_VBN P_NN values_NNS and_CC overestimated_VBN predicted_VBD MICs_NP ,_, which_WDT is_VBZ not_RB the_DT case_NN except_IN for_IN cephaloridine_NN ,_, for_IN which_WDT P_NN was_VBD determined_VBN by_IN the_DT method_NN of_IN Zimmerman_NP and_CC Rosselet_NP ,_, and_CC benzylpenicillin_NN ,_, but_CC in_IN the_DT latter_JJ case_NN the_DT MIC_NN might_MD be_VB higher_JJR as_IN higher_JJR antibiotic_JJ concentrations_NNS have_VBP not_RB been_VBN tested_VBN ._SENT Otherwise_RB the_DT predicted_VBN and_CC observed_VBN MICs_NNS are_VBP in_IN fair_JJ (_( benzylpenicillin_NN and_CC carbenicillin_NN )_) to_TO good_JJ (_( all_DT others_NNS )_) agreement_NN ._SENT It_PP is_VBZ important_JJ to_TO note_VB that_IN because_IN the_DT antibiotic_JJ concentrations_NNS used_VBN for_IN the_DT permeability_NN measurements_NNS are_VBP much_RB lower_JJR than_IN those_DT used_VBN in_IN the_DT Zimmermann-Rosselet_NP experiments_NNS ,_, the_DT new_JJ method_NN could_MD be_VB more_RBR easily_RB affected_VBN by_IN efflux_NN systems_NNS since_IN their_PP$ influence_NN is_VBZ not_RB masked_VBN by_IN a_DT high_JJ antibiotic_JJ influx_NN ._SENT However_RB ,_, as_RB for_IN beta-lactamase_NN ,_, the_DT importance_NN of_IN efflux_NN in_IN the_DT experiment_NN will_MD depend_VB on_IN the_DT relative_JJ affinity_NN and_CC expression_NN level_NN of_IN these_DT systems_NNS compared_VBN to_TO BlaR-CTD_NN ._SENT This_DT restriction_NN does_VBZ not_RB seem_VB to_TO apply_VB to_TO our_PP$ conclusions_NNS ,_, since_IN the_DT rate_NN of_IN BlaR-CTD_JJ acylation_NN was_VBD high_JJ in_IN all_DT cases_NNS ._SENT Showing_VBG that_IN the_DT measured_VBN P_NN values_NNS are_VBP compatible_JJ with_IN the_DT MICs_NP for_IN a_DT beta-lactamase-overproducing_NN mutant_NN is_VBZ thus_RB a_DT useful_JJ control_NN of_IN the_DT validity_NN of_IN the_DT method_NN ._SENT Thanks_NNS to_TO the_DT progress_NN in_IN genetic_JJ engineering_NN methods_NNS ,_, it_PP is_VBZ now_RB easy_JJ to_TO selectively_RB inactivate_VB chromosomal_JJ beta-lactamases_NNS or_CC efflux_NN systems_NNS in_IN gram-negative_JJ bacteria_NNS ._SENT Therefore_RB ,_, we_PP think_VBP that_IN despite_IN some_DT limitations_NNS ,_, the_DT method_NN described_VBN here_RB will_MD be_VB of_IN great_JJ interest_NN to_TO more_RBR accurately_RB measure_VB low_JJ outer_JJ membrane_NN permeabilities_NNS encountered_VBN in_IN some_DT genera_NNS and/or_CC resistant_JJ mutants_NNS ._SENT Time-dependent_JJ labeling_VBG of_IN the_DT 50_CD %_NN trichloroacetic_JJ acid-3.75_NN %_NN tungstosilicic_JJ acid_JJ insoluble_JJ fraction_NN of_IN E._NP aerogenes_NP Time-dependent_NP labeling_VBG of_IN the_DT 50_CD %_NN trichloroacetic_JJ acid-3.75_NN %_NN tungstosili_NNS 